MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroimaging in Parkinson’s disease dementia: Connecting the dots

R. Weil, J. Hsu, R. Darby, L. Soussand, M. Fox (Nashville, TN, USA)

Meeting: 2019 International Congress

Abstract Number: 1984

Keywords: Dementia, Magnetic resonance imaging(MRI)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To identify the neural substrates of Parkinson’s disease dementia (PDD) and Parkinson’s disease with Mild Cognitive Impairment (PD-MCI) using a network mapping approach.

Background: Dementia is a common and devastating symptom of PD but the anatomical substrates are still not clear. Neuroimaging abnormalities in PDD have been reported throughout the brain and are largely inconsistent across studies. Here we test whether heterogeneous findings for PDD localise to a specific brain network by using a new approach: coordinate-based network mapping.

Method: We used a literature search to identify studies reporting neuroimaging correlates of PDD (n=11). We restricted our search to studies of brain atrophy and hypometabolism that compared PD dementia to those without cognitive involvement.  We used a standard coordinate-based ALE meta-analysis to examine consistency in neuroimaging findings.  We then used coordinate-based network mapping to test whether neuroimaging findings localize to a common brain network.  This uses resting state functional connectivity from a large cohort of normal subjects (n=1000) to identify the network of regions connected to reported neuroimaging coordinates.

Results: The standard ALE meta-analysis did not identify brain regions associated with PDD.  In contrast, our new approach showed that heterogeneous neuroimaging findings localize to a network centred on the hippocampus.  Next we tested for stage specificity by using studies of PD-MCI (n=15).  Coordinate-based network mapping revealed that correlates of PD-MCI fell within a network centred on the posterior default mode network.

Conclusion: Our results link heterogeneous neuroimaging findings in PDD to a common network centred on the hippocampus, pointing to a central role for the hippocampi in established PD dementia.  In contrast, our finding that posterior brain networks are involved in PD-MCI sheds light onto the earlier stages of PDD. This has implications for understanding the progression of dementia in PD and for testable hypotheses regarding therapeutic targets.

To cite this abstract in AMA style:

R. Weil, J. Hsu, R. Darby, L. Soussand, M. Fox. Neuroimaging in Parkinson’s disease dementia: Connecting the dots [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuroimaging-in-parkinsons-disease-dementia-connecting-the-dots/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroimaging-in-parkinsons-disease-dementia-connecting-the-dots/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley